Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01109303
Other study ID # PEJ-446
Secondary ID
Status Completed
Phase N/A
First received April 21, 2010
Last updated December 19, 2012
Start date October 2008
Est. completion date January 2012

Study information

Verified date December 2012
Source Hopital de l'Enfant-Jesus
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

Ankle fracture is frequent and its number is increasing. In Canada, surgical treatment of these lesions is advised and the options currently used all have in common a rigid fixation of the syndesmosis which results in residual stiffness and a high level of secondary surgery, mostly to remove the implant.

The purpose of the study is to compare the treatment of ankle syndesmotic rupture by a dynamic fixation to a static fixation suggesting that the dynamic fixation method will improve the Olerud-Molander functional score of more than 15 points at the 3 months follow-up.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date January 2012
Est. primary completion date February 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- men or women = 18 years-old;

- ankle fracture type 44-C (AO classification) with an AP, lateral and mortise X-ray views of the ankle and an AP and lateral X-ray views of the leg;

- open fractures (Gustilo I-IIIb) or closed;

- trauma-surgery delay of less than 7 days;

- consent form signed.

Exclusion Criteria:

- ankle fractures without syndesmotic lesion;

- fracture associated with neuro-vascular lesions (Gustillo IIIc);

- pathologic fracture;

- fracture in a polytraumatized patient;

- fracture of a bone in the ipsilateral leg;

- men or women > 65 years-old;

- chronic cardiac insufficiency (ejection fraction < 30%);

- lower leg chronic venous insufficiency;

- neuro-arthropathic foot (Charcot, diabetes, etc…);

- body mass index = 40;

- past medical history of fracture of the same ankle;

- medical conditions too serious for a surgery;

- men or women unfit to consent;

- any other conditions that make the examinator thinks that the follow up would be problematic.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
TightRope System- Arthrex® / Dynamic Implant
Patients are operated on using a dynamic implant, the TightRope System by Arthrex®. The ankle is immobilized in a plaster boot for 6 weeks.
Screw fixation - Synthes® / Static Implant
Patients are operated on using a static implant, the rigid four-cortices 3,5 mm screw fixation by Synthes®. The ankle is immobilized in a plaster boot for 6 weeks.

Locations

Country Name City State
Canada CHA-Pavillon Enfant-Jésus Québec Quebec

Sponsors (2)

Lead Sponsor Collaborator
Hopital de l'Enfant-Jesus Arthrex, Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Olerud-Molander score The Olerud-Molander scoring scale was chosen because it adequately represents the ankle performance following surgery (trauma or elective basis). It comprises nine functional parameters which are concerned with primary complaints, the ability to perform simple tasks and the everyday life activities. 3 months after surgery No
Secondary Rate of secondary surgery To measure the rate of secondary surgery due to infection or implant removal. Every secondary surgery during the following year counts, even for the same patient. within one year following surgery No
Secondary Radiological loss of reduction Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the anteroposterior (AP) and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm.
Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group.
2 weeks after surgery No
Secondary Implant failure Rate of implant failure (with or without a second surgery for removal) will be measured in each group. one year after surgery No
Secondary Radiological loss of reduction Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm.
Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group.
6 weeks after surgery No
Secondary Radiological loss of reduction Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm.
Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group.
12 weeks after surgery No
Secondary Radiological loss of reduction Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm.
Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group.
6 months after surgery No
Secondary Radiological loss of reduction Adequate reduction of the syndesmosis is evaluated on a simple X-ray in the AP and mortise views; the "clear space" is the distance between the medial side of fibula and the incisural surface of tibia (1 cm above tibial pilon) and cannot be more than 6 mm.
Rate of loss of reduction and the range of this loss over 6 mm will be calculated in each group.
12 months after surgery No
Secondary American Orthopaedic Foot and Ankle Society (AOFAS) score of hindfoot An evaluation of the function (7 criteria), alignment (1 criteria) and pain (1 criteria), for a maximum of 100 points on the AOFAS scale. 12 weeks after surgery No
Secondary AOFAS score of hindfoot An evaluation of the function (7 criteria), alignment (1 criteria) and pain (1 criteria), for a maximum of 100 points on the AOFAS scale. 6 months after surgery No
Secondary AOFAS score of hindfoot An evaluation of the function (7 criteria), alignment (1 criteria) and pain (1 criteria), for a maximum of 100 points on the AOFAS scale. 12 months after surgery No
Secondary Return to professional activities This measure will be determined in days after surgery, for rate of 50% and 100% of the usual work load. 3 months after surgery No
Secondary Pain on visual analog scale (VAS) Pain is described with the VAS, which ranges from 1 to 10. 12 weeks after surgery No
Secondary Pain on VAS Pain is described with the VAS, which ranges from 1 to 10. 12 weeks after surgery No
Secondary Pain on VAS Pain is described with the VAS, which ranges from 1 to 10. 12 months after surgery No
Secondary Range of motion With a goniometer, a measure of the dorsal flexion (normal value 20°) and plantar flexion (40°) will be taken. Inversion and eversion will be measured according to this scale: + = weak ; ++ = middle ; +++ = complete. 12 weeks after surgery No
Secondary Range of motion With a goniometer, a measure of the dorsal flexion (normal value 20°) and plantar flexion (40°) will be taken. Inversion and eversion will be measured according to this scale: + = weak ; ++ = middle ; +++ = complete. 6 months after surgery No
Secondary Range of motion With a goniometer, a measure of the dorsal flexion (normal value 20°) and plantar flexion (40°) will be taken. Inversion and eversion will be measured according to this scale: + = weak ; ++ = middle ; +++ = complete. 12 months after surgery No
Secondary Muscular trophicity measure of the leg This measure is taken with a metric band 15 cm under the inferior patellar pole and must be compared to normal side. It is defined in cm with a precision of 0.5 cm. A ratio injured side/normal side will be calculated. 12 weeks after surgery No
Secondary Muscular trophicity measure of the leg This measure is taken with a metric band 15 cm under the inferior patellar pole and must be compared to normal side. It is defined in cm with a precision of 0.5 cm. A ratio injured side/normal side will be calculated. 6 months after surgery No
Secondary Muscular trophicity measure of the leg This measure is taken with a metric band 15 cm under the inferior patellar pole and must be compared to normal side. It is defined in cm with a precision of 0.5 cm. A ratio injured side/normal side will be calculated. 12 months after surgery No
Secondary Ankle circumference measure This measure is taken with a metric band at the bimalleolar level and must be compared to normal side. It is defined in cm with a precision of 0.5 cm. A ratio injured side/normal side will be calculated. 12 weeks after surgery No
Secondary Ankle circumference measure This measure is taken with a metric band at the bimalleolar level and must be compared to normal side. It is defined in cm with a precision of 0.5 cm. A ratio injured side/normal side will be calculated. 6 months after surgery No
Secondary Ankle circumference measure This measure is taken with a metric band at the bimalleolar level and must be compared to normal side. It is defined in cm with a precision of 0.5 cm. A ratio injured side/normal side will be calculated. 12 months after surgery No